251 related articles for article (PubMed ID: 33595883)
1. Novel agents for atopic dermatitis in patients over 50 years of age: A case series.
Kiely L; Bowe S; O'Connor C; Bennett M; Bourke J; Murphy M
Dermatol Ther; 2021 Mar; 34(2):e14890. PubMed ID: 33595883
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis.
Siegels D; Heratizadeh A; Abraham S; Binnmyr J; Brockow K; Irvine AD; Halken S; Mortz CG; Flohr C; Schmid-Grendelmeier P; Van der Poel LA; Muraro A; Weidinger S; Werfel T; Schmitt J;
Allergy; 2021 Apr; 76(4):1053-1076. PubMed ID: 33074565
[TBL] [Abstract][Full Text] [Related]
3. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
[TBL] [Abstract][Full Text] [Related]
5. Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey.
Drucker AM; Lam M; Flohr C; Thyssen JP; Kabashima K; Bissonnette R; Dlova NC; Aoki V; Chen M; Yu J; Zhu JW; Micieli R; Nosbaum A
Dermatitis; 2022 May-Jun 01; 33(3):200-206. PubMed ID: 35170524
[TBL] [Abstract][Full Text] [Related]
6. Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
de Bruin-Weller M; Pink AE; Ferrucci SM; Patrizi A; Svensson A; Schuttelaar MLA; Tauber M; Ardeleanu M; Jayawardena S; Daoud M
J Dermatolog Treat; 2022 Aug; 33(5):2565-2570. PubMed ID: 35255779
[TBL] [Abstract][Full Text] [Related]
7. Relative efficacy of systemic treatments for atopic dermatitis.
Seger EW; Wechter T; Strowd L; Feldman SR
J Am Acad Dermatol; 2019 Feb; 80(2):411-416.e4. PubMed ID: 30296535
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
[TBL] [Abstract][Full Text] [Related]
9. Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?
Alexander H; Patton T; Jabbar-Lopez ZK; Manca A; Flohr C
F1000Res; 2019; 8():. PubMed ID: 30774935
[TBL] [Abstract][Full Text] [Related]
10. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
Bosma AL; Spuls PI; Garcia-Doval I; Naldi L; Prieto-Merino D; Tesch F; Apfelbacher CJ; Arents BWM; Barbarot S; Baselga E; Deleuran M; Eichenfield LF; Gerbens LAA; Irvine AD; Manca A; Mendes-Bastos P; Middelkamp-Hup MA; Roberts A; Seneschal J; Svensson Å; Thyssen JP; Torres T; Vermeulen FM; Vestergaard C; von Kobyletzki LB; Wall D; Weidinger S; Schmitt J; Flohr C
Br J Dermatol; 2020 Jun; 182(6):1423-1429. PubMed ID: 31444799
[TBL] [Abstract][Full Text] [Related]
11. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
Patruno C; Stingeni L; Hansel K; Ferrucci SM; Tavecchio S; Fabbrocini G; Nisticò SP; Foti C; De Prezzo S; Napolitano M
Dermatol Ther; 2020 May; 33(3):e13290. PubMed ID: 32125741
[TBL] [Abstract][Full Text] [Related]
13. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
[TBL] [Abstract][Full Text] [Related]
14. [Current and upcoming treatments of adult atopic dermatitis].
Lacour JP
Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Beck LA; Thaçi D; Deleuran M; Blauvelt A; Bissonnette R; de Bruin-Weller M; Hide M; Sher L; Hussain I; Chen Z; Khokhar FA; Beazley B; Ruddy M; Patel N; Graham NMH; Ardeleanu M; Shumel B
Am J Clin Dermatol; 2020 Aug; 21(4):567-577. PubMed ID: 32557382
[TBL] [Abstract][Full Text] [Related]
16. Dupilumab: A review of its use in the treatment of atopic dermatitis.
Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
[TBL] [Abstract][Full Text] [Related]
17. Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study.
Schneeweiss MC; Kim SC; Wyss R; Schneeweiss S; Merola JF
J Am Acad Dermatol; 2021 Feb; 84(2):300-311. PubMed ID: 33038471
[TBL] [Abstract][Full Text] [Related]
18. Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.
Fishbein AB; Silverberg JI; Wilson EJ; Ong PY
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):91-101. PubMed ID: 31474543
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab for the Treatment of Atopic Dermatitis.
Ferreira S; Torres T
Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):230-240. PubMed ID: 29422431
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT).
Irvine AD; Jones AP; Beattie P; Baron S; Browne F; Ashoor F; O'Neill L; Rosala-Hallas A; Sach T; Spowart C; Taams L; Walker C; Wan M; Webb N; Williamson P; Flohr C;
Br J Dermatol; 2018 Dec; 179(6):1297-1306. PubMed ID: 29727479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
